A collaborative clinic between contraception and sexual health services and an adult congenital heart disease clinic

Journal of Family Planning and Reproductive Health Care

Volumn 33, Issue 1, 2007, Pages 17-21

  Rogers, Paula ^a   Mansour, Diana ^a   Mattinson, Alison ^a   O'Sullivan, John J ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cardiology; Congenital heart disease; Contraception; Long acting reversible contraception; Sexual health services

Indexed keywords

GESTAGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDOM; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; HEALTH CENTER; HEALTH SERVICE; HORMONAL CONTRACEPTION; HUMAN; PATIENT EDUCATION; SEXUAL BEHAVIOR; SEXUAL HEALTH; UNITED KINGDOM;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CONTRACEPTION BEHAVIOR; COOPERATIVE BEHAVIOR; FEMALE; GREAT BRITAIN; HEALTH CARE SURVEYS; HEART DEFECTS, CONGENITAL; HUMANS; MIDDLE AGED; ORGANIZATIONAL CASE STUDIES; REPRODUCTIVE HEALTH SERVICES;

EID: 33846440490     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118907779399648     Document Type: Article

References (19)

1. Leonard H, O'Sullivan JJ, Hunter S. Family planning requirements in the adult congenital heart disease clinic. Heart 1996; 76: 60-62.
2. Somerville J. The Denolin Lecture: The woman with congenital heart disease. Eur Heart J 1998; 19: 1766-1775.
3. Swan L, Hillis WS, Cameron A. Family planning requirements of adults with congenital heart disease. Heart 1997; 78: 9-11.
4. British Cardiac Society. Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK. Heart 2002; 88(Suppl. 1): 1-14.
5. Seaworth BJ, Durack DT. Infective endocarditis in obstetric and gynecologic practice. Am J Obstet Gynecol 1986; 154: 180-188.
6. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use (3rd edn). Geneva, Switzerland: WHO, 2004.
7. Murray S, Hickey JB, Houang E. Significant bacteraemia associated with replacement of intrauterine contraceptive device. Am J Obstet Gynecol 1987; 156: 698-700.
8. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004; 30: 29-42.
9. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. J Fam Plann Reprod Health Care 2004; 30: 99-108.
10. British National Formulary (No. 50). London, UK: British Medical Association and the Royal Pharmaceutical Society of Great Britain, September 2005; 268.
11. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. Contraception 1998; 57: 315-324.
12. Frederiksen MC. Depot medroxyprogesterone acetate contraception in women with medical problems. J Reprod Med 1996; 41: 414-418.
13. Sonmezer M, Atabekoglu C, Cengiz B, Dokmeci F, Cengiz SD. Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum. Eur J Contracept Reprod Health Care 2005; 10: 9-14.
14. MacKenzie IZ, Turner E, O'Sullivan GM, Guillebaud J. Two hundred out-patient laparoscopic clip sterilizations using local anaesthesia. Br J Obstet Gynaecol 1987; 94: 449-453.
15. Ubeda A, Labastida R, Dexeus S. Essure: a new device for hysteroscopic tubal sterilisation in an outpatient setting. Fertil Steril 2004; 82: 196-199.
16. Kerin JF, Carignan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study. Aust N Z J Obstet Gynaecol 2001; 41: 364-370.
17. Stevens-Simon C. Providing effective reproductive healthcare and prescribing contraceptives for adolescents. Pediatr Rev 1998; 19: 409-417.
18. Siu S, Chitayat D, Webb G. Pregnancy in women with congenital heart defects: what are the risks? Heart 1999; 81: 225-226.
19. Confidential Enquiries into Maternal and Child Health (CEMACH). Why Mothers Die 2000-2002. Sixth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London, UK: RCOG Press, 2004.